Harpoon Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Harpoon Therapeutics

27/03/2023 22:21

* Harpoon Therapeutics Inc  HARP.OQ  reported a quarterly
adjusted
loss of 55 cents​​ per share for the quarter ended in December.
The mean expectation of eight analysts for the quarter was for a
loss of 47 cents per share.
    * Revenue fell 5.5% to $4.09 million from a year ago;
analysts
expected $7.04 million. 
    * Harpoon Therapeutics Inc's reported EPS for the quarter
was a
loss of 55 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Harpoon Therapeutics Inc shares had fallen by 7.3% this
quarter.
    * The company reported a quarterly loss of $18.42 million.
    * Wall Street's median 12-month price target for Harpoon
Therapeutics Inc is $6.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 27 at 09:20 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.47          -0.55          Missed
 Sep. 30 2022      -0.56          -0.35          Beat
 Jun. 30 2022      -0.56          -0.53          Beat
 Mar. 31 2022      -0.55          -0.62          Missed